Saturday, January 28, 2023

Bombay High Court to Hear COVID-19 Vaccine Death Case: Medical Student Compelled to Receive Covishield (Oxford/AstraZeneca) Viral Vector Vaccine

Date:

A petitioner in India’s Bombay High Court claims that the COVID-19 vaccine called Covishield killed his daughter and is now seeking compensation for the loss. The claimant argues that his daughter’s death is directly linked to the side effects of Covishield, the viral vector COVID-19 vaccine originally developed by the University of Oxford, licensed by AstraZeneca for the Indian subcontinent and other parts of the world, then licensed for production and commercialization to the Serum Institute of India (SII), the world’s busiest vaccine producer. Originally labeled ChAdOx1 nCoV-19, or the Oxford/AstraZeneca vaccine, the U.S. Food, and Drug Administration canceled clinical trials in the U.S. earlier during the pandemic due to safety incidents. India’s drug regulator (Drug Controller General of India) granted emergency authorization for the product at the start of 2021 by SII. TrialSite reported that SII made moves last year to lobby the government to remove all liability for these COVID-19 vaccines, much like is the case in the United States with the PREP Act. The claimant has served multiple parties from SII to the Bill Gates Foundation.

Now demanding approximately $125.8K, the petitioner also includes Bill Gates as well as SII in the lawsuit via the Bombay high court notice. The medical student’s father included the Bill Gates foundation as they partnered with SII to promote the vaccines. Covered by multiple Indian mainstream media such as the Hindustan Times, “The Bombay High Court has sought response from the Serum Institute of India, Microsoft Founder Bill Gates, and others on a petition from a man who blamed the side effects from Covishield as the reason behind his daughter’s death.”

Who is the petitioner?

Dilip Lunwat of Aurangabad in central west India near Mumbai (Bombay) is the petitioner. He has filed and is seeking a response from the Bombay High Court as well as the Union government, Maharashtra government, and Drug Controller General of India.

Who was his daughter?

Snehal Lunawat was a medical student who was forced to take the vaccine by her medical school in Nashik because she fell under the category of health worker. She was a doctor and lecturer at a dental college.

What’s the father’s mission?

In addition to seeking justice for the death of his daughter, Mr. Lunwat seeks retribution for the “many more people who are likely to be murdered” due to similar adverse events, says the petition.

What happened?

A day after receiving the Covishield vaccine on January 28, Snehal experienced both headache and vomiting which led to her hospitalization. There, the attending staff found she was bleeding in her brain, reports Hindustan Times.

She died on March 1 as a result of vaccine side effects, or so her father claims.

What’s the evidence?

A report was submitted by the national government’s adverse event post-immunization (AEFI) committee on October 2.

What justices?

S V Gangapurwala and Madhav Jamdar.

What justices?

S V Gangapurwala and Madhav Jamdar.

S V Gangapurwala

Madhav Jamdar

 Call to Action: When is the hearing?

The matter will be heard on November 17th, 2022.

References

A petitioner in India’s Bombay High Court claims that the COVID-19 vaccine called Covishield killed his daughter and is now seeking compensation for the loss. The claimant argues that his daughter’s death is directly linked to the side effects of Covishield, the viral vector COVID-19 vaccine originally developed by University of Oxford, licensed by AstraZeneca for the Indian subcontinent and other parts of the world, then licensed for production and commercialization to the Serum Institute of India (SII), the world’s busiest vaccine producer. Originally labeled ChAdOx1 nCoV-19, or the Oxford/AstraZeneca vaccine, the U.S. Food and Drug Administration cancelled clinical trials in the U.S. earlier during the pandemic due to safety incidents. India’s drug regulator (Drug Controller General of India) granted emergency authorization for the product at the start of 2021 by SII. TrialSite reported that SII made moves last year lobby the government to remove all liability for these COVID-19 vaccines, much like is the case in the United States with the PREP Act. The claimant has served multiple parties from SII to the Bill Gates Foundation.

Source: trialsitenews.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Shocking! Just bow your head in shame before reading this news of woman molestation

Banda (Uttar Pradesh): A horrific incident of women molestation has come to light from Yogi Adityanath ruled Uttar...

Anant Ambani, Radhika Merchant visited Guruvayur and Tirupati temple a week after engagement

Thiruvananthapuram: Business tycoon Mukesh Ambani’s younger son Anant Ambani who got engaged to Radhika Merchant, visited Kerala to...

Republic Day 2023: Egyptian President Abdel Fattah El-Sisi to witness parade as chief guest today

New Delhi: As India celebrates its 74th Republic Day on Thursday, Egyptian President Abdel Fattah El-Sisi is all...